Abstract Background: There has been uncertainty until recently whether OSA, is sufficient to cause persistent daytime pulmonary hypertension and right ventricular dysfunction.
Introduction
Obstructive sleep apnea (OSA) is a disorder that is characterized by obstructive apneas and hypopneas due to repetitive collapse of the upper airway during sleep [1] .
OSA is associated with repetitive nocturnal arterial O 2 desaturation and intrathoracic negative pressure swings and an acute increase in pulmonary artery pressure. Experimentally induced intermittent hypoxemia in rodents, have been proved to develop pulmonary vascular remodeling and sustained PH and right ventricular hypertrophy. Until recently, however, it was unclear whether episodic nocturnal hypoxemia associated with OSA was sufficient to cause similar changes in humans [2] .
Due to the lack of population-based studies, the true prevalence of PH is not known [3] . Many of the studies that discussed the consequences of untreated OSA are looking for associations between the prevalence of a cardiovascular consequence at a given time with the severity/presence of OSA [4] .
This controversy appears to have been resolved by several recent studies that have shown pulmonary hypertension in 20-40% of patients with OSA in the absence of other known cardiopulmonary disorders and reductions in pulmonary artery pressure in patients with OSA after nocturnal continuous positive airway pressure (CPAP) treatment [2, 5] .
Aim of the work
The aims of this study, were to investigate whether OSA by itself without any other cardiac or lung disease can lead to pulmonary hypertension, and to assess the effect of CPAP therapy on pulmonary artery pressure.
Subjects and methods
This study was carried out at the Sleep-Disordered Breathing Unit, Chest Medicine Department, Mansoura University Hospitals in the period between June 2009 and September 2011. The study was performed on 54 OSA patients (29 males and 25 females with age ranged from 30 to 67 years), with >5 and without any heart or lung diseases.
Inclusion criteria
Middle-aged adults with OSA and no other concomitant heart and lung diseases that may affect pulmonary hemodynamics enrolled in the study fulfilled the following inclusion criteria:
1. Polysomnographic diagnosis of OSA with an apnea-hypopnea index (AHI)> 5 with symptoms suggestive of OSA (e.g. excessive day time sleepiness, snoring, nocturnal chocking and witnessed apnea).
2. normoxemia and normocapnia based on ABGs.
3. Absence of chronic lung disease, cor pulmonale, myocardial, pericardial, valvular heart disease or arrhythmias based on clinical and laboratory tests (chest X-ray, electrocardiogram, echocardiography).
Exclusion criteria
Other causes of pulmonary hypertension: COPD patients, chronic thromboembolic disease, connective tissue diseases, interstitial lung diseases, mitral valve diseases or congestive heart failure.
Patients subgroups
The selected patients were classified according to AHI into two groups:
(I) Severe OSA patient with AHI > 30 [6] (38 cases, 22 males and 16 females with mean age 46.34 ± 6.56) (II) Non severe OSA patient with AHI 6 30 (16 cases, 7 males and 9 females with mean age 46.13 ± 6.98).And also were classified according to pulmonary artery pressure measurement into two groups: (a) OSA patients with pulmonary hypertension (i.e. mPAP > 25 mmHg) [7] . (b) OSA patients without pulmonary hypertension (i.e. mPAP 6 25 mmHg).
All patients were subjected to 1. Thorough history taking with stress on: Age, chest symptoms, special habits especially smoking and alcohol intake, cardiac symptoms, evaluation of excessive day time sleepiness using the Epworth sleepiness scale [8] and sleep disordered breathing symptoms such as snoring, nocturnal choking, witnessed apnea at night, and Berlin questionnaire [9] . 2. Physical examinations with stress on: Neck circumference.
Body mass index (BMI). Chest and heart examination. mitral valve diseases or congestive heart failure) and for the assessment of pulmonary artery systolic pressure and mean pulmonary artery pressure (PASP-mPAP): (a) PASP measurement: PASP can be reliably determined from peak TR jet velocity, using the simplified Bernoulli equation and combining this value with an estimate of the RA pressure: PASP = 4(V)2 + RA pressure where V is the peak velocity (in meters per second) of the tricuspid valve regurgitant jet [10, 11] . (b) mPAP: mPAP can be measured by acceleration time (AT) of the pulmonary velocity flow measured by a pulsed Doppler of the pulmonary artery in systole, whereby mean PA pressure = 79 À (0.45 · AT) [11, 12] . The same group also found that in patients with ATs <120 ms, the formula for mean PA pressure is 90 _ (0.62 _ AT) and performed better [13] .
9. CPAP therapy: All OSA patients with pulmonary hypertension were advised to use the CPAP therapy. Only 14 patients agreed to use the CPAP therapy, and follow up echocardiography was done to them after 6 months and only 10 patients have completed the study. CPAP pressure was adjusted according to the following equation: Auto-CPAP setting: reference pressure (Pref) = 0.193 · BMI + 0.077 · neck circumference + 0.02 · apnea + hypopnea index À 0.611 and Pref À4 to Pref + 3 cm H 2 O pressure limits [14] .
Some modification according to each patient's comfort and limitation of side effects was done to the pressure adjustment. CPAP therapy at least 6 h/day was documented by patients' bed partner in a sleep diary. The follow up sessions were done at 7, 30, and 60 days after the initiation of the CPAP therapy with a phone call by the patient in between sessions and written information about any trouble shouting problems during CPAP use.
Statistical analysis
Data were analyzed using SPSS (Statistical Package for Social Sciences) version 10. Qualitative data were presented as number and percent. Comparison between groups was done by the Chi-square test. Quantitative data were tested for normality by the Kolmogrov-Smirnov test. Normally distributed data were presented as mean ± SD. Student's t-test was used to compare between two groups. Non parametric variables were presented as Median (min -max) and the Mann-Whitney test (U test) was used to compare between two groups. P < 0.05 was considered to be statistically significant.
Results
The study included 29 male and 25 female OSA patients; mean age was 46.28 ± 6.62. The mean of BMI was 30.28 ± 3.72, the median AHI was 57.55 (9.2 -132.6) and the median of mPAP was 25 (10 -42) . Severe OSA with AHI > 30 was present in (70.3%) and included 38 cases, 22 males and 16 females with mean age 46.34 ± 6.56. Non severe OSA with AHI < 30 was present in (29.7%) and included 16 cases, 7 males and 9 females with mean age 46.13 ± 6.98. In this study the selected patients' spirometric pulmonary function (FEV1, FVC, FEV1/ FVC) of all the studied OSA patients were nearly within the There were no significant differences in spirometric pulmonary function tests (FEV1, FVC, FEV1/FVC) between severe OSA patients compared to non severe OSA patients, and there were no significant differences in spirometric pulmonary function testes as regards FEV1, FVC, and FEV1/ FVC in pulmonary hypertensive patients versus non pulmonary hypertensive patients. There were significantly higher BMI, neck circumference, Epworth scale, Berlin questionnaire and AHI in severe OSA patients Vs non severe OSA patients (p = <.001). There were significantly lower awake SaO 2 and PaO 2 in severe versus non severe OSA patients (p = <.001) ( Table 1) .
Pulmonary hypertension (PH) i.e. mPAP > 25 mmHg was present in 44.4% of OSA patients. (Table 2 ).
There were significantly higher PASP and mPAP in severe OSA patients versus non severe OSA patients (Table 3) .
There were significantly more nocturnal oxygen desaturation (significant lower basal SaO 2 , minimum SaO 2 and higher desaturation index p = <.001) in severe OSA patients compared to non severe OSA patients (Table 4) .
There were significantly higher BMI, neck circumference and AHI in OSA patients with PH compared to OSA patients without PH. Awake SaO 2 was significantly lower in OSA patients with PH compared to OSA patients without PH (Table 5) .
There was significantly higher ODI in OSA patients with PH versus OSA patients without PH (Table 6 ).
There were significant positive correlations between AHI and (BMI, ODI, PASP and mPAP) (p < 0.001 for each). Also there were positive correlations between mPAP and (BMI, ODI). However, there were significant negative correlations between AHI and (PaO 2 , Basal SaO 2 and Minimum SaO 2 ) (P < 0.001 for each), there were significant negative correlations between mPAP and (PaO 2 and Minimum SaO 2 ) (P = 0.005, P < 0.001 respectively) ( Table 7) .
There were significant reductions in both mPAP and PASP after 6 months of CPAP treatment (p = 0.007 0, 0.005 respectively) with percentage of reduction after 6 months of CPAP therapy in both mPAP, PASP (26.91% and 23.11% respectively) ( Table 8) .
Discussion
There has been uncertainty until recently as to whether OSA, is sufficient to cause persistent daytime PHT and right ventricular dysfunction. Some studies have concluded that PHT and right heart disease, if occur in OSA, are always attributable to other coexisting conditions such as COPD or morbid obesity that resulted in chronic hypoxemia secondary to pulmonary ventilation-perfusion inequality, alveolar hypoventilation, or both. However, these studies were conducted among patients with a mixture of OSA and chronic lung disease, making it difficult to determine the relative contributions of sleep apnea-related intermittent hypoxia to PHT and right heart disease [15] .
This study was carried out on 54 patients of OSA and no other concomitant heart or lung diseases that may affect pulmonary hemodynamics.
Our study revealed that Epworth sleepiness scale (ESS) and Berlin questionnaire were significantly higher in severe OSA versus non severe OSA (p = .001 for each, Table 1 ), which signify that both questionnaire may be a predictor of severity of OSA Sharma et al. [6] had reported Berlin questionnaire as a predictor to high risk category of OSA with high sensitivity (86%) and specificity (95%). Also, Steven [6] has found a significant positive correlation between ESS and AHI and concluded that if ESS was more than 10, sleep related breathing disorders (SRBDs) should be suspected. They also advised to assess ESS in SRBDs to rule out or prove OSA and hence manage it early in the course of the disease. In our study there were significantly higher BMI and neck circumference in severe OSA patients compared to non severe OSA patients and there were significantly higher BMI and neck circumference in patients with PH patients versus non PH patients. Fishman et al. [16] concluded that neck circumference greater than 40 cm predicts OSA with sensitivity of 61% and specificity of 93%, regardless of gender. Also, Young and his colleagues reported that neck circumference was the most powerful predictor of OSA among all anthropometric variables studied, suggesting that the central obesity rather than generalized distribution of body fat is important for the development of OSA [17] . Obesity leads to increased amount of fat in the neck which plays the greatest role in OSA [18] . It is presumed that increased fat deposition in the neck region or adjacent to the upper airway on the pharyngeal wall can impinge on the pharyngeal lumen and predispose its collapse during sleep. There is a link between obesity and PH which may be attributed to the relative deficiency of release of adiponectin, which has an important role in pulmonary vascular inflammation suppression by inhibiting vasoconstricting substances [19] . In this study there was a significant positive correlation between AHI and BMI and also there was a significant positive correlation between mPAP and BMI ( Table 7) . This was in agreement with Chaouat et al. [20] who have reported a significant positive correlation between AHI and BMI, and Arias et al. [21] who reported high BMI in OSA patients with PH compared to OSA without PH.
The prevalence of pulmonary hypertension (PH) i.e. (mPAP > 25 mmHg) [7] in the studied OSA patients was 44.4% (24 out of 54 patients, Table 2 ), and the median of mPAP of total group of patients was 25 (10 -42, Table 1 ). OSA alone may cause mild to moderate pH, but coexisting day time hypoxia is typically required for sustained severe pH and cor pulmonale [22] . Minai et al. [23] reported that mild, moderate and even severe PH (i.e. mPAP P 40 mmHg) can occur in patients with OSA. Moreover, Fletcher et al. [24] had reported pulmonary hypertension in severe OSA in the absence of hypoxemic lung disease.
The incidence of PH in OSA patients has been estimated to be 20-40%. [2, 5] . Our result was close to Laks et al. [25] who reported PH in 42% of OSA patients and Saijkov et al. [26] who reported PH in 41% of OSA patients. OSA is characterized by episodes of apnea and hypopnea during sleep, these episodes are caused by partial or complete upper airway obstruction. Episodes of oxygen desaturation cause a transient increase in pulmonary artery and pulmonary wedge pressures and permanent PH Marrone and Bonsignore [27] Diurnal PH was elucidated by the sustained hypoxia which results in remodeling of the pulmonary vasculature, with intimal smooth muscle thickening, endothelial perforation, and fibroelastosis [28] .
Daytime hypoxemia has been reported to develop in patients with OSA [29, 30] . In our study OSA patients were without resting hypoxemia but there were significantly lower awake PaO 2 and SaO 2 , in severe OSA patients versus non severe OSA patients (P < 0.001, for each, Table 1 ). Meanwhile there was no significant difference in awake PaCO 2 in severe OSA versus non severe OSA patients (Table 1) . This was in agreement with Fanfulla et al. [31] who found significantly lower PaO 2 and SaO 2 in severe OSA versus non severe OSA and no significant difference in PaCO 2 in severe OSA versus non severe OSA. In this study, there was no significant correlation between AHI and PaCO 2 (P = 0.053, Table 7 ). This was in agreement to Ayappa et al. [32] who demonstrated no significant correlation between PaCO 2 and OSA severity.
In our study there was significantly lower awake SaO 2 in the pulmonary hypertensive group versus the non pulmonary hypertensive group (P = 0.015, Table 5 ) this was in agreement with most of the other studies [23, 21, 33] who reported a significant reduction in daytime SaO 2 in the pulmonary hypertensive group versus teh non pulmonary hypertensive group. Also in this study both awake PaO 2 and PaCO 2 were not significantly different between the pulmonary hypertensive group and the non pulmonary hypertensive group (Table 5 ). These were in agreement with Alchanatis et al. [33] and Leech [34] . OSA patients without resting hypoxemia had frequent episodes of nocturnal desaturation (saw-tooth pattern) that are more in REM and abolished by CPAP [35] . In this study there were significantly more nocturnal oxygen desaturation (significant lower basal SaO 2 , minimum SaO 2 and higher desaturation index p = <.001) in severe OSA patients compared to non severe OSA patients (Table 4 ). This was as in agreement with Fanfulla et al. [31] . Also in this study there were significant negative correlations between AHI and (PaO 2 , basal SaO 2 and minimum SaO 2 ) and significant positive correlation between AHI and ODI, Table 7 ). This was in accordance to Chaouat et al. [20] who have reported that AHI was significantly negatively correlated with (PaO 2 , basal SaO 2 and minimum SaO 2 ).
Nocturnal hypoxemia may be crucial to the development of pulmonary hypertension [25] . The mechanisms by which alveolar hypoxia leads to PH are probably both, pulmonary vasoconstriction and remodeling of pulmonary vascular bed [36] . It has been hypothesized that isolated nocturnal hypoxemia (without significant daytime hypoxemia) could lead to pulmonary hypertension [26] . In this study patients were without daytime hypoxemia, in the same time the rate of PH encountered in our OSA patients was high (44.4%), denoting that repeated nocturnal hypoxemia alone is the leading factor in the pathogenesis of PH.
Chronic intermittent hypoxia activates homeostatic mechanisms in the respiratory system that induce changes in gene expression by mediation of several transcription factors, such as hypoxia-inducible factors (HIF), both HIF-1a and HIF2a, are involved in physiological responses of pulmonary arterioles to chronic intermittent hypoxia, collectively producing hypertrophy of the pulmonary arteriolar smooth muscle [31, 37] .
In this study there were significantly higher ODI and significantly lower minimum SaO 2 in the pulmonary hypertensive group than the non pulmonary hypertensive group (Table 6 ). This was in agreement with [25, 21] . Also in this study there was a significant positive correlation between mPAP and ODI, and there was a significant negative correlation between mPAP and PaO 2 and minimum SaO 2 . These were in agreement with Arias et al. [21] .
In this study mPAP and PASP were significantly higher in severe OSA patients versus non severe OSA patients (Table 3) . Also, in our study AHI was significantly positive correlated with mPAP and PASP (Table 7) . Leech [34] had concluded that the severity of OSA is correlated to pulmonary artery pressure.
These could be explained according to Han et al. [2] who stated that severe OSA is associated with repetitive nocturnal arterial O 2 desaturation and intrathoracic negative pressure swings with an acute increase in pulmonary artery pressure and also intermittent hypoxemia for several hours per day developed pulmonary vascular remodeling and sustained pulmonary hypertension.
In our study, 10 out of 24 patients of OSA with PH who have been treated with CPAP for 6 months, without medical treatment of PH, have remarkably lowered mPAP (from 35 (28-40) to 26 (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) , P = 0.007), and also lowered PASP (from 45 (40-50) to 35 (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) , with percentage of reduction in both mPAP and PASP 26.91, 23.11 respectively (Table 8) . This was in agreement with Alchanatis et al. [33] study which also demonstrated a marked reduction in mPAP after effective treatment of CPAP therapy for 6 months. Also, in accordance to Arias et al. [21] who have reported a reduction in PASP in OSA patients with PH after effective treatment with CPAP therapy for 6 months. More recently, Oliveira et al. [38] have reported the beneficial effect of CPAP treatment in reducing the risk of developing pulmonary hypertension and right ventricular failure in OSA patients. These findings signify that there is a causal relationship between OSA and PH.
Conclusion
OSA is associated with pulmonary hypertension which increased with severity. Nocturnal O 2 desaturation and increased BMI are important risk factors in the pathogenesis of pulmonary hypertension in OSA patients. Improvement of pulmonary hypertension through controlling OSA by CPAP therapy signifies that OSA plays a crucial role in the pathogenesis of pulmonary hypertension.
Recommendations CPAP therapy should be advised to all OSA patients with pulmonary hypertension. All patients with pulmonary hypertension should be screened for the presence of associated SRBDs. 
